Analysts at StockNews.com assumed coverage on shares of Ekso Bionics (NASDAQ:EKSO – Get Free Report) in a note issued to investors on Saturday. The brokerage set a “hold” rating on the stock. A number ...
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Control Bionics Ltd has successfully raised $310,000 through the issuance of shortfall shares from its Non ...
Control Bionics (ASX:CBL) has acquired a 20% stake for US$250,000 including cash and in-kind contributions in US-based Neuro Elite Athletics, which is the company behind the NeuroBounce program ...